Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)

Diabetes Care

Volumn 31, Issue 1, 2008, Pages 146-150

  Bingley, Polly J ^a,c   Mahon, Jeffrey L ^b   Gale, Edwin A M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RADIOIMMUNOASSAY; RISK ASSESSMENT; SCHOOL CHILD; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; EUROPE; FAMILY; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; MULTICENTER STUDY; PUBERTY; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; AUTOIMMUNITY; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; EUROPE; FAMILY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; NIACINAMIDE; PUBERTY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 38149011472     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0103     Document Type: Article

References (20)

1. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC: Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667, 2004
2. Mrena S, Virtanen SM, Laippala P, Kulmala P, Hannila M-L, Akerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 29:662-667, 2006
3. The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group: Intervening before the onset of type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia 46:339-346, 2003
4. The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group: European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931, 2004
5. Bingley PJ, Gale EAM: Progression to type 1 diabetes in ICA positive relatives in the European Nicotinamide Diabetes Intervention Trial (ENDIT): the role of additional immune, genetic and metabolic markers of risk. Diabetologia 41:881-890, 2006
6. Tanner JM: Growth at Adolescence. Oxford, U.K., Blackwell, 1962
7. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM: Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710, 1997
8. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME: Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39:578-582, 1993
9. Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA: Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17-24, 1995
10. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495, 2004
11. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
12. Collett D: Modelling Survival Data in Medical Research. London, Chapman & Hall, 1994
13. Greenbaum CJ, Kahn SE, Palmer JP: Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM. Diabetes 45:1631-1634, 1996
14. Bingley PJ, Caldas G, Bonfanti R, Gale EAM: Nicotinamide and insulin secretion in normal subjects. Diabetologia 36:675-677, 1993
15. Brandou F, Brun J-F, Mercier J: Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab 90:761-767, 2005
16. Gungor N, Saad R, Janosky J, Arslanian SA: Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47-55, 2004
17. Karne RJ, Chen H, Sullivan G, Quon MJ: Letter re: limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab 90:4418-4419, 2005
18. Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D, Chase HP, Eisenbarth GS; DPT-1 Study Group: Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing. J Pediatr 150:31-36, 2007
19. Dabelea D, D'Agostino RB, Mayer EJ, Pettitt DJ, Imperatore G, Dolan LM, Pihoker C, Hillier TA, Marcovina SM, Linder B, Ruggiero AM, Hamman RF: Testing the accelerator hypothesis. Diabetes Care 29:290-294, 2006
20. Wilkin TJ: Testing the accelerator hypothesis: body size, β-cell function, and age at onset of type 1 (autoimmune) diabetes (Letter). Diabetes Care 29:1462-1463, 2006